A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures (FR_FNS)

January 14, 2022 updated by: AO Innovation Translation Center
In comparison to previous implants, the Femoral neck system (FNS) is an approved implant by the competent authorities (CE mark). It is designated to stabilize medial femoral neck fractures in a minimal invasive technique. The implant combines an angular stable device with screw in screw technology for rotational stability. Therefore the purpose of this focused registry is to investigate how the newly developed and approved implant called FNS is performing clinically and radiologically in terms of surgical technique, intra- and postoperative complications and short term outcome.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

All patients included are treated as per standard or care and followed up from the time point of enrollment until at least three months after surgery as described below. Data of a visit after 6 months and 12 months are collected if bone union according to the RUSH score is not complete after 3 or 6 months respectively or if the patient has persistent or increasing pain on the operated site.

Preoperative:

  • Patient details
  • Fracture Classification and comminution based on CT
  • Pre-fracture HHS and EQ5D
  • X-rays

Intraoperative:

  • Surgery details
  • Defined intraoperative complications
  • Intraoperative fluoroscopy: hip ap (with leg 15° internally rotated) and lateral after reduction and after implant placement

Postoperative:

  • X-ray prior to any mechanical load: hip ap (with leg 15° internally rotated) and lateral

    6 weeks and 3 months FU:

  • Defined postoperative complications
  • HSS and EQ5D
  • X-rays

Study Type

Observational

Enrollment (Actual)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tirol
      • Innsbruck, Tirol, Austria, 6020
        • Medizinische Universität Innsbruck
    • Baden-Württemberg
      • Ulm, Baden-Württemberg, Germany, 89081
        • Ulm University
    • Thüringen
      • Jena, Thüringen, Germany, 07740
        • Friedrich-Schiller-Universitat Jena
      • Luzern, Switzerland, 6006
        • Luzerner Kantonsspital
      • Zürich, Switzerland, 8063
        • Stadtspital Triemli
    • BL
      • Bruderholz, BL, Switzerland, 4401
        • Kantonsspital Baselland
    • Ticino
      • Lugano, Ticino, Switzerland, 6900
        • Ospedale Regionale di Lugano

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients suffering from a femoral neck fracture (AO/OTA 31-B1:3) with the need of a fixation using the FNS.

Description

Inclusion Criteria:

  • Age 18 years and older
  • Diagnosis of a medial femoral neck fracture (AO/OTA 31-B1:3) with the need of a fixation using the FNS.
  • Ability to understand the content of the patient information/Informed Consent Form
  • Willingness and ability to participate in the registry according to the Registry Plan (RP)
  • Signed and dated Ethics Committee (EC)/Institutional Review Board (IRB) approved written informed consent

Exclusion Criteria:

  • Pathological fracture
  • Additional acute fracture
  • Any not medically managed severe systemic disease
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the registry period
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present registry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Femoral Neck Fractures AO/OTA 31-B1:3
Fixation using the implant FNS.
Surgical intervention using the FNS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of complications within the first 3 months after surgery
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fracture mechanism
Time Frame: Pre-operatively (Day -1)
Classification of the fracture mechanism in one of the following group: Fall from standing height , Falls from elevated height, Road traffic accident or Other causes
Pre-operatively (Day -1)
Classification of the fracture
Time Frame: Pre-operatively (Day -1)
Classification of the fracture using the Garden classification and the AO/AOTA classification
Pre-operatively (Day -1)
Time from injury to surgery
Time Frame: Surgery (Day 0)
Time in hours from the injury to the start of the surgery
Surgery (Day 0)
Length of surgery
Time Frame: Surgery (Day 0)
Time in minutes from first incision to closure
Surgery (Day 0)
Harris Hip Score
Time Frame: Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery
Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery
EQ5D-5L
Time Frame: Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery
Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery
Radiological bone union (RUSH score)
Time Frame: 6 weeks, 3 months, 6 months and 12 months after surgery
RUSH score
6 weeks, 3 months, 6 months and 12 months after surgery
Quality of reduction (Garden's alignment index and Lowell's criteria)
Time Frame: Surgery (Day 0)
Garden's alignment index and Lowell's criteria
Surgery (Day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karl Stoffel, Prof, Kantonsspital Baselland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2017

Primary Completion (Actual)

November 30, 2020

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

March 27, 2015

First Submitted That Met QC Criteria

April 16, 2015

First Posted (Estimate)

April 21, 2015

Study Record Updates

Last Update Posted (Actual)

January 28, 2022

Last Update Submitted That Met QC Criteria

January 14, 2022

Last Verified

December 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fracture

Clinical Trials on FNS

3
Subscribe